Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $15000.0.

  • Taysha Gene Therapies' Interest Expenses fell 3750.0% to $15000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $73000.0, marking a year-over-year decrease of 9079.45%. This contributed to the annual value of $102000.0 for FY2024, which is 9795.92% down from last year.
  • Latest data reveals that Taysha Gene Therapies reported Interest Expenses of $15000.0 as of Q3 2025, which was down 3750.0% from $17000.0 recorded in Q2 2025.
  • In the past 5 years, Taysha Gene Therapies' Interest Expenses ranged from a high of $1.5 million in Q3 2023 and a low of $15000.0 during Q3 2025
  • Over the past 4 years, Taysha Gene Therapies' median Interest Expenses value was $672000.0 (recorded in 2022), while the average stood at $596600.0.
  • Its Interest Expenses has fluctuated over the past 5 years, first skyrocketed by 10446.43% in 2023, then tumbled by 9836.85% in 2024.
  • Taysha Gene Therapies' Interest Expenses (Quarter) stood at $1.3 million in 2022, then tumbled by 45.36% to $713000.0 in 2023, then plummeted by 96.91% to $22000.0 in 2024, then tumbled by 31.82% to $15000.0 in 2025.
  • Its Interest Expenses was $15000.0 in Q3 2025, compared to $17000.0 in Q2 2025 and $19000.0 in Q1 2025.